N-((5-Methyl-1,2,4-oxadiazol-3-yl)methyl)propan-2-amine

Catalog No.: 
ACYMBY939
CAS No.: 
915924-63-9
Molecular Formula: 
C7H13N3O
Molecular Weight: 
155.20
N-((5-Methyl-1,2,4-oxadiazol-3-yl)methyl)propan-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((5-Methyl-1,2,4-oxadiazol-3-yl)methyl)propan-2-amine
IUPAC NameN-((5-methyl-1,2,4-oxadiazol-3-yl)methyl)propan-2-amine
MDL No.MFCD08691561
Molecular FormulaC7H13N3O
Molecular Weight155.20
SMILESCC(NCC1=NOC(C)=N1)C
InChI KeyPVGPTGOCYTVTGP-UHFFFAOYSA-N
SynonymN-[(5-METHYL-1,2,4-OXADIAZOL-3-YL)METHYL]PROPAN-2-AMINE;N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]propan-2-amine(SALTDATA: FREE);CHEMBRDG-BB 4012594;1,2,4-Oxadiazole-3-methanamine, 5-methyl-N-(1-methylethyl)-
CAS No.915924-63-9

Synthetic Route by SureRoute

1. ACYMBY939 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDHWR716 route compound structure diagram
    ACDHWR71629552-58-7In Stock
  2. Plus
  3. ACGMVB387 route compound structure diagram
    ACGMVB3871192-80-9In Stock
  4. Then
  5. ACYMBY939 route product structure diagram
    ACYMBY939915924-63-9
Inquiry

2. ACYMBY939 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDHWR716 route compound structure diagram
    ACDHWR71629552-58-7In Stock
  2. Plus
  3. ACGHIZ628 route compound structure diagram
    ACGHIZ62825977-23-5In Stock
  4. Then
  5. ACYMBY939 route product structure diagram
    ACYMBY939915924-63-9
Inquiry

3. ACYMBY939 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLBXO673 route compound structure diagram
    ACLBXO6731184986-84-2In Stock
  4. Then
  5. ACYMBY939 route product structure diagram
    ACYMBY939915924-63-9
Inquiry

Comments (0)